Does TOFACITINIB Cause Product dose omission issue? 5,646 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5,646 reports of Product dose omission issue have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.6% of all adverse event reports for TOFACITINIB.
5,646
Reports of Product dose omission issue with TOFACITINIB
3.6%
of all TOFACITINIB reports
34
Deaths
538
Hospitalizations
How Dangerous Is Product dose omission issue From TOFACITINIB?
Of the 5,646 reports, 34 (0.6%) resulted in death, 538 (9.5%) required hospitalization, and 5 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 5,646 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which TOFACITINIB Alternatives Have Lower Product dose omission issue Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN